MEDICUS PHARMA LTD (MDCX) Stock Overview
NASDAQ:MDCX - CA58471K2020 - Common Stock
MDCX Key Statistics, Chart & Performance
The current stock price of MDCX is 2.01 USD. In the past month the price decreased by -24.51%.
MDCX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.89 | 372.07B | ||
| AMGN | AMGEN INC | 13.06 | 153.33B | ||
| GILD | GILEAD SCIENCES INC | 14.45 | 138.80B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.44 | 101.82B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.52 | 60.58B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.50B | ||
| ARGX | ARGENX SE - ADR | 75.61 | 42.89B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.56 | 38.72B | ||
| INSM | INSMED INC | N/A | 30.46B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.86B | ||
| NTRA | NATERA INC | N/A | 22.94B | ||
| BIIB | BIOGEN INC | 8.57 | 20.12B |
Related stock screener links
About MDCX
Company Profile
Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. The company is headquartered in Toronto, Ontario. The company went IPO on 2023-10-11. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly-owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agents to eradicate tumor cells. The Company’s wholly-owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The firm investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The firm is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.
Company Info
MEDICUS PHARMA LTD
100 King Street West, Suite 3400
TORONTO ONTARIO CA
Employees: 0
Phone: 17323003046
MEDICUS PHARMA LTD / MDCX FAQ
What is the stock price of MEDICUS PHARMA LTD today?
The current stock price of MDCX is 2.01 USD. The price increased by 3.61% in the last trading session.
What is the ticker symbol for MEDICUS PHARMA LTD stock?
The exchange symbol of MEDICUS PHARMA LTD is MDCX and it is listed on the Nasdaq exchange.
On which exchange is MDCX stock listed?
MDCX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MEDICUS PHARMA LTD stock?
9 analysts have analysed MDCX and the average price target is 20.06 USD. This implies a price increase of 898.01% is expected in the next year compared to the current price of 2.01. Check the MEDICUS PHARMA LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MEDICUS PHARMA LTD worth?
MEDICUS PHARMA LTD (MDCX) has a market capitalization of 37.63M USD. This makes MDCX a Nano Cap stock.
How many employees does MEDICUS PHARMA LTD have?
MEDICUS PHARMA LTD (MDCX) currently has 0 employees.
What are the support and resistance levels for MEDICUS PHARMA LTD (MDCX) stock?
MEDICUS PHARMA LTD (MDCX) has a support level at 1.93 and a resistance level at 1.95. Check the full technical report for a detailed analysis of MDCX support and resistance levels.
Should I buy MEDICUS PHARMA LTD (MDCX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MDCX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MDCX, evaluating the profitability, health, valuation and growth aspects
- MEDICUS PHARMA LTD (MDCX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDICUS PHARMA LTD (MDCX) Sales and EPS estimates to see what analysts future expectations are.
- MEDICUS PHARMA LTD (MDCX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDICUS PHARMA LTD (MDCX) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDICUS PHARMA LTD (MDCX) Stock Chart to make your own analysis
- MEDICUS PHARMA LTD (MDCX) Latest news and press-releases to stay up to date.
Does MEDICUS PHARMA LTD (MDCX) stock pay dividends?
MDCX does not pay a dividend.
What is the Price/Earnings (PE) ratio of MEDICUS PHARMA LTD (MDCX)?
MEDICUS PHARMA LTD (MDCX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.87).
What is the Short Interest ratio of MEDICUS PHARMA LTD (MDCX) stock?
The outstanding short interest for MEDICUS PHARMA LTD (MDCX) is 3.02% of its float. Check the ownership tab for more information on the MDCX short interest.
MDCX Technical Analysis
MDCX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to MDCX. MDCX may be in some trouble as it scores bad on both profitability and health.
MDCX Financial Highlights
Over the last trailing twelve months MDCX reported a non-GAAP Earnings per Share(EPS) of -1.87. The EPS increased by 24.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -195% | ||
| ROE | -319.45% | ||
| Debt/Equity | 0.07 |
MDCX Forecast & Estimates
9 analysts have analysed MDCX and the average price target is 20.06 USD. This implies a price increase of 898.01% is expected in the next year compared to the current price of 2.01.